RP
Richard Pulik (CFO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale, 1 filed past the two-business-day deadline), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $9.1M of ROIV (406,731 sh across 2 lots, as filed), executed Dec 23 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells · 1 late
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$9.1M
shares × price, as filed
Last traded
Dec 23 2025
Filed Dec 29 2025
Median ADV $222.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $9.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ROIVRecent filings
ROIVSALE
Roivant Sciences Ltd.
View filing →
$9.1M406,731 sh across 2 lots
Exec Dec 23 2025
Filed Dec 29 2025 · 5:30 PM ET †